Search - tctmd.com

Displaying 561 - 580 of 889

Sort: Relevancy | Date

News Daily News

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Caitlin E. Cox

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Todd Neale

December 10, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Daily News

医院如何处理 PCI 恰当性报告？有人认为，基本什么也没做

Shelley Wood

November 18, 2015

News Daily News

¿Qué Hacen los Hospitales Con los Informes sobre la Conveniencia de Realizar o No PCI? Algunos Piensan que No Mucho

Shelley Wood

November 18, 2015

News Daily News

What Are Hospitals Doing With PCI Appropriateness Reports? Some Say, Not Much

Shelley Wood

November 18, 2015

News Daily News

专家们就指南推荐的多支冠脉病变患者护理方法的优点进行辩论

L.A. McKeown

November 17, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

News Daily News

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

L.A. McKeown

November 17, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Daily News

COURAGE at 15 Years: Still No Survival Advantage for PCI

L.A. McKeown

November 10, 2015

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Conference News AHA 2015

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

Shelley Wood

November 08, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

October 13, 2015

Advertisement

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

医院如何处理 PCI 恰当性报告？有人认为，基本什么也没做

¿Qué Hacen los Hospitales Con los Informes sobre la Conveniencia de Realizar o No PCI? Algunos Piensan que No Mucho

What Are Hospitals Doing With PCI Appropriateness Reports? Some Say, Not Much

专家们就指南推荐的多支冠脉病变患者护理方法的优点进行辩论

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

COURAGE at 15 Years: Still No Survival Advantage for PCI

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content